Skip to main content

Mind Medicine MindMed Inc

For the period ended Dec 31, 2023. Filed Feb 28, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 28, 2024

DFTX$34.64-2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney (included on signature page hereto)

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Rob Barrow, Schond L. Greenway and Carrie F. Liao as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and substitution, for him or her and in his or her name, place, and stead, in any and all capacities (including his/her capacity as a director and/or officer of Mind Medicine (MindMed) Inc.) to sign any or all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they, he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents or any of them, or their, his, or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Robert BarrowChief Executive Officer and DirectorFebruary 28, 2024
Robert Barrow(Principal Executive Officer)
/s/ Schond L. GreenwayChief Financial OfficerFebruary 28, 2024
Schond L. Greenway(Principal Financial Officer)
/s/ Carrie F. LiaoChief Accounting OfficerFebruary 28, 2024
Carrie F. Liao, CPA(Principal Accounting Officer)
/s/ Suzanne BruhnDirectorFebruary 28, 2024
Suzanne Bruhn, PhD
/s/ David GryskaDirectorFebruary 28, 2024
David Gryska
/s/ Roger CrystalDirectorFebruary 28, 2024
Roger Crystal, MD
/s/ Andreas KrebsDirectorFebruary 28, 2024
Andreas Krebs
/s/ Carol ValloneDirectorFebruary 28, 2024
Carol Vallone
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.